A research for effects of primary aldosteronism on renal function in patients with type 2 diabetes

Impact of primary aldosteronism on renal function in patients with type 2 diabetes - Impact of primary aldosteronism on renal function in patients with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039791

Enrollment

1500

Registered

2020-03-12

Start date

2020-03-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus, primary aldosteronism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All outpatients with type 2 diabetes who visited our hospital between April 2017 and March 2018.

Exclusion criteria

Exclusion criteria: Patients with type 1 diabetes, gestational diabetes, specific types of diabetes, Cushing's syndrome, renal cell carcinoma, glomerulonephritis, and untreated primary aldosteronism. Patients with estimated glomerular filtration rate < 15 mL/min/1.73m2.

Design outcomes

Primary

Measure	Time frame
estimated glomerular filtration rate	—

Secondary

Measure	Time frame
urine albumin-to-creatinine ratio	—

Countries

Japan

Contacts

Public ContactSho Katsuragawa

Yokohama Rosai Hospital Endocrinology and Diabetes Center

sho.k.2876@gmail.com+81-45-474-8111

Outcome results